Creo Medical Group Plc (CREO) Ord GBP0.001
Sell:13.25pBuy:13.50p
0.38p
(2.73%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:13.25p
Buy:13.50p
Change:0.38p
(2.73%)
0.38p
(2.73%)Prices delayed by at least 15 minutes
Sell:13.25p
Buy:13.50p
Change:0.38p
(2.73%)
0.38p
(2.73%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 30 May 2025 | Kevin Timothy CroftonChairman of the Board | Buy Regular purchase transaction | 701,750 | £0.16 | £110,525.63 | 5,447,416 |
| 20 January 2025 | Christopher Paul (Chris) HancockCTO | Buy Regular purchase transaction | 4,712 | £0.19 | £899.99 | 4,829,369 |
| 16 January 2025 | Richard John ReesCFO | Buy Regular purchase transaction | 4,712 | £0.19 | £899.99 | 3,041,252 |
| 16 January 2025 | Craig Jonathan GullifordCEO | Buy Regular purchase transaction | 4,712 | £0.19 | £899.99 | 1,657,483 |
| 13 December 2024 | Kevin Timothy CroftonChairman of the Board | Buy Regular purchase transaction | 1,179,000 | £0.17 | £200,547.90 | 4,745,666 |
| 24 October 2024 | Richard John ReesCFO | Buy Regular purchase transaction | 76,740 | £0.20 | £15,355.67 | 3,036,540 |
| 24 October 2024 | Richard John ReesCFO | Buy Regular purchase transaction | 98,000 | £0.20 | £19,609.80 | 2,959,800 |
| 24 October 2024 | Richard John ReesCFO | Sell Regular sell transaction (market) | 174,740 | £0.20 | £34,948.00 | 2,861,800 |
| 31 July 2024 | Christopher Paul (Chris) HancockCTO | Buy Regular purchase transaction | 2,748 | £0.33 | £899.97 | 4,819,161 |
| 31 July 2024 | Richard John ReesCFO | Buy Regular purchase transaction | 2,748 | £0.33 | £899.97 | 2,822,711 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 13 December 2024 | Kevin Timothy CroftonChairman of the Board | Buy Regular purchase transaction | 1,179,000 | £0.17 | £200,547.90 | 4,745,666 |
| 30 May 2025 | Kevin Timothy CroftonChairman of the Board | Buy Regular purchase transaction | 701,750 | £0.16 | £110,525.63 | 5,447,416 |
| 24 October 2024 | Richard John ReesCFO | Sell Regular sell transaction (market) | 174,740 | £0.20 | £34,948.00 | 2,861,800 |
| 24 October 2024 | Richard John ReesCFO | Buy Regular purchase transaction | 98,000 | £0.20 | £19,609.80 | 2,959,800 |
| 24 October 2024 | Richard John ReesCFO | Buy Regular purchase transaction | 76,740 | £0.20 | £15,355.67 | 3,036,540 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.